BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11686530)

  • 1. Effect of faecal occult blood testing on colorectal cancer mortality in the surveillance of subjects at moderate risk of colorectal neoplasia: a case-control study.
    Lamah M; Norris J; Caffarey SM; Broughton M; Marks CG
    Int J Colorectal Dis; 2001 Sep; 16(5):313-7. PubMed ID: 11686530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
    Hardcastle JD; Chamberlain JO; Robinson MH; Moss SM; Amar SS; Balfour TW; James PD; Mangham CM
    Lancet; 1996 Nov; 348(9040):1472-7. PubMed ID: 8942775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study to evaluate efficacy of screening for faecal occult blood.
    Lazovich D; Weiss NS; Stevens NG; White E; McKnight B; Wagner EH
    J Med Screen; 1995; 2(2):84-9. PubMed ID: 7497161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
    Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
    Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised study of screening for colorectal cancer with faecal-occult-blood test.
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Lancet; 1996 Nov; 348(9040):1467-71. PubMed ID: 8942774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
    Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated faecal occult blood testing is associated with decreased advanced colorectal cancer risk: A population-based study.
    James PD; Rabeneck L; Yun L; Paszat L; Baxter NN; Govindarajan A; Antonova L; Tinmouth JM
    J Med Screen; 2018 Sep; 25(3):141-148. PubMed ID: 28862521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology.
    Bampton PA; Sandford JJ; Cole SR; Smith A; Morcom J; Cadd B; Young GP
    Gut; 2005 Jun; 54(6):803-6. PubMed ID: 15888788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy.
    Zappa M; Castiglione G; Grazzini G; Falini P; Giorgi D; Paci E; Ciatto S
    Int J Cancer; 1997 Oct; 73(2):208-10. PubMed ID: 9335444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds.
    Jørgensen OD; Kronborg O; Fenger C
    Gut; 2002 Jan; 50(1):29-32. PubMed ID: 11772963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E; Idigoras I; Uranga B; Pérez R; Irurzun A; Gutiérrez-Ibarluzea I; Fraser CG; Portillo I;
    BMC Cancer; 2017 Aug; 17(1):577. PubMed ID: 28851318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
    Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
    Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options for screening for colorectal cancer in the Royal Air Force: a cost-effectiveness evaluation.
    Daniels K; McKee M
    J R Army Med Corps; 1995 Oct; 141(3):142-50. PubMed ID: 8568748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
    Heresbach D; Manfredi S; D'halluin PN; Bretagne JF; Branger B
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):427-33. PubMed ID: 16538116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers.
    Niv Y; Lev-El M; Fraser G; Abuksis G; Tamir A
    Gut; 2002 Jan; 50(1):33-7. PubMed ID: 11772964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?
    Lee TJ; Hull MA; Rajasekhar PT; Clifford GM; Ritchie M; James P; McNally RJ; Rutter MD; Rees CJ
    Digestion; 2012; 85(4):278-81. PubMed ID: 22538301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopic surveillance of first-degree relatives of colorectal cancer patients in a faecal occult blood screening programme.
    Sassoli de Bianchi P; Campari C; Mancini S; Giuliani O; Landi P; Paterlini L; Naldoni C; Finarelli AC; Falcini F; Ponz de Leon M; Sassatelli R; Borciani E; Fornari F; Gatti G; Zatelli M; Zurlini C; Rossi F; Corradini R; Olivetti R; Manfredi M; Baldazzi P; Nannini R; Zanarini S; Matarese VG; Palmonari C; Triossi O; Gordini S; Vattiato R; Colamartini A; Palazzi M; Severi M; Briganti L; Giovanardi M; Casale C; Bucchi L
    Cancer Epidemiol; 2013 Aug; 37(4):469-73. PubMed ID: 23683843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.
    Robinson MH; Hardcastle JD; Moss SM; Amar SS; Chamberlain JO; Armitage NC; Scholefield JH; Mangham CM
    Gut; 1999 Oct; 45(4):588-92. PubMed ID: 10486370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening.
    Berry DP; Clarke P; Hardcastle JD; Vellacott KD
    Br J Surg; 1997 Sep; 84(9):1274-6. PubMed ID: 9313712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.